Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Goldstone Capital Group is a Hong Kong-based investment holding company focused on investing in listed and unlisted enterprises across various industries, including telecommunications, energy, biotechnology, medicals, pharmaceuticals, security investment, social welfare, and environmental issues. The company does not itself conduct drug development or clinical trials but may invest in companies that do. While Goldstone Capital Group invests across several sectors—including biotech/pharma—it does not operate as a life sciences or healthcare product developer or service provider itself. It should be considered an investment holding group with diversified sector exposure rather than a biotech/pharma/CRO/CDMO entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Goldstone Capital Group.